Today, Johnson & Johnson MedTech, a leader in neurovascular care, announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the TRUFILL n‑BCA Liquid Embolic ...
December 11, 2025—Medtronic announced that the Onyx liquid embolic system (LES)—Onyx 18 and Onyx 34—is now indicated in the United States for embolization of the middle meningeal artery (MMA) as an ...
After 8 weeks, patients with chronic subdural hematoma who received atorvastatin had a greater difference in hematoma volume vs. patients who received placebo, according to phase 2 clinical trial data ...
After a hit to the head or a fall, people, especially seniors, can develop a dangerous pooling of blood and fluid between the brain's surface and it's protective covering, the dura. These "subdural ...
A dramatic, threefold reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to ...
The MRCSDH is the first nationwide study in mainland China to assess the safety and efficacy of different treatment approaches for CSDH. Its findings can help the medical community make informed ...
Johnson & Johnson MedTech announced that the FDA has approved an expanded indication for the company’s TruFill n-But ...
A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback